Corporate Banner
Satellite Banner
Biologics & Bioprocessing
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - September 2013


3rd Annual Pre-Filled Syringes Summit

24 Sep 2013 - 26 Sep 2013 - Washington DC, USA



Bookmark and Share


Get clarity on regulations and learn to develop safer, more robust pre-filled syringes…
The market for pre-filled syringes continues to grow healthily, but why is the field still held back by the same issues year after year? Component quality still isn’t consistent; package integrity is still proving tough to test robustly enough. Regulations on human factors and combination products are as unclear as ever.

The 3rd Annual Pre-Filled Syringes Summit, will bring together leaders from all areas of pre-filled syringe development, manufacturing and regulation. Together we will share and discuss ideas to help overcome the problems holding back progress. So join us to help uncover and develop practical, near term, solutions to solve themNOW.

With an agenda put together with the help of thought leaders from the FDA,Genentech, Pfizer, Amgen, Eli Lilly, Baxter, Sanofi, Novartis, Janssen,Hospira, GlaxoSmithKline and many more, the 3rd Annual Pre-filled Syringes Summit will dig deeper than any other meeting. You will leave with immediately actionable solutions to help get your pre-filled syringe projects moving in the right direction. Whether you need clarity on regulations, or want an opportunity to network and discuss the problems you currently face, The 3rd Annual Pre-Filled Syringes Summit is the only North American meeting this year that can truly deliver.


Further information
Scientific News
Immunotherapy Agent Benefits Patients with Drug-Resistant Multiple Myeloma in First Human Trial
Daratumumab proved generally safe in patients, even at the highest doses.
Inciting an Immune Attack On Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
'Fountain of Youth' Protein Points to Possible Human Health Benefit
Patients with higher blood levels of growth factor have lower risk of cardiovascular problems.
Lemon Juice and Human Norovirus
Citric acid may prevent the highly contagious norovirus from infecting humans, scientists discovered from the German Cancer Research Center.
Study Backs Flu Vaccinations for Elderly
Brown University researchers found vaccines well matched to the year’s flu strain significantly reduce deaths and hospitalizations compared to when the match is poor, suggesting that vaccination indeed makes a difference.
Inciting an Immune Attack on Cancer Cells
A new minimally invasive vaccine that combines cancer cells and immune-enhancing factors could be used clinically to launch a destructive attack on tumors.
Protein Found to Play a Key Role in Blocking Pathogen Survival
Calprotectin fends off microbial invaders by limiting access to iron, an important nutrient.
Scroll Up
Scroll Down
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!